Actualités Cipher Pharmaceuticals Inc - CPH | Actions Toronto Stock Exchange

OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX

NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated...

Cipher Pharmaceuticals Reports Voting Results for the Election of Directors

MISSISSAUGA, Ontario, June 12, 2019 (GLOBE NEWSWIRE) -- Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company"), in accordance...

Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercialize A-101 40% topical sol...

The agreement will expand the availability of the first and only U.S. FDA-approved prescription product for...

Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome

Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome PR Newswire MISSISSAUGA...

Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals

Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals PR Newswire MISSISSAUGA...

Can-Fite Files Clinical Trial Application in Canada for Piclidenoson Ahead of Upcoming Acrobat Rheumatoid Arthritis Phase III...

Can-Fite Files Clinical Trial Application in Canada for Piclidenoson Ahead of Upcoming Acrobat Rheumatoid Arthritis Phase III Study PR...

Cipher Pharmaceuticals Announces Preliminary Q2 2016 Results Highlighted by 30+% Revenue Growth and $3.0+million Cash from Op...

Cipher Pharmaceuticals Announces Preliminary Q2 2016 Results Highlighted by 30+% Revenue Growth and $3.0+million Cash from Operations PR...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cipher Pharmaceuticals Inc (CPH)

Outils de qualité professionnelle, pour des investisseurs individuels.

CPH Actualités

OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX

Cipher Pharmaceuticals Reports Voting Results for the Election of Directors

Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercialize A-101 40% topical sol...

Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome

Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals

Can-Fite Files Clinical Trial Application in Canada for Piclidenoson Ahead of Upcoming Acrobat Rheumatoid Arthritis Phase III...

Cipher Pharmaceuticals Announces Plans to Voluntarily Delist from NASDAQ

Cipher Pharmaceuticals Reports Q3 2016 Financial Results

Cipher Pharmaceuticals Announces Management Change

Cipher Pharmaceuticals Responds to Request for Comment from IIROC

Notice of Cipher Pharmaceuticals Inc. Q3 2016 Conference Call

Cipher Pharmaceuticals appoints Stephen Lemieux as Chief Financial Officer

Cipher Pharmaceuticals Reports Q2 2016 Results Highlighted by 32% Revenue Growth and $3.1 Million Cash from Operations

Cipher Pharmaceuticals Inc. Announces Changes to its Board of Directors

Cipher Pharmaceuticals Announces Preliminary Q2 2016 Results Highlighted by 30+% Revenue Growth and $3.0+million Cash from Op...

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cipher Pharmaceuticals Inc (CPH) Actualités

Cipher Pharmaceuticals Inc (CPH)

Outils de qualité professionnelle, pour des investisseurs individuels.

CPH Actualités

OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX

Cipher Pharmaceuticals Reports Voting Results for the Election of Directors

Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercialize A-101 40% topical sol...

Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome

Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals

Can-Fite Files Clinical Trial Application in Canada for Piclidenoson Ahead of Upcoming Acrobat Rheumatoid Arthritis Phase III...

Cipher Pharmaceuticals Announces Plans to Voluntarily Delist from NASDAQ

Cipher Pharmaceuticals Reports Q3 2016 Financial Results

Cipher Pharmaceuticals Announces Management Change

Cipher Pharmaceuticals Responds to Request for Comment from IIROC

Notice of Cipher Pharmaceuticals Inc. Q3 2016 Conference Call

Cipher Pharmaceuticals appoints Stephen Lemieux as Chief Financial Officer

Cipher Pharmaceuticals Reports Q2 2016 Results Highlighted by 32% Revenue Growth and $3.1 Million Cash from Operations

Cipher Pharmaceuticals Inc. Announces Changes to its Board of Directors

Cipher Pharmaceuticals Announces Preliminary Q2 2016 Results Highlighted by 30+% Revenue Growth and $3.0+million Cash from Op...

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application